Literature DB >> 25713737

Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives.

Bin Kong1, Yu Liu1, He Huang1, Hong Jiang1, Congxin Huang1.   

Abstract

Atrial fibrillation (AF) is a frequent cause of stroke. More than 90% of thrombi were found in the left atrial appendage (LAA) in non-valvular AF. Transcatheter LAA closure has been developed as a novel approach to reduce the risk of stroke in patients with AF over the last decade. In this article, we review the recent advances and propose the possible challenges regarding the LAA closure for thromboembolism prevention in patients with AF.

Entities:  

Keywords:  Atrial fibrillation (AF); left atrial appendage (LAA) closure; stroke

Year:  2015        PMID： 25713737      PMCID： PMC4321064          DOI： 10.3978/j.issn.2072-1439.2015.01.20

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  20 in total

1.  The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.

Authors:  Stacey L Amorosi; Shannon Armstrong; Lisa Da Deppo; Susan Garfield; Kenneth Stein
Journal:  Europace       Date:  2014-03-30       Impact factor: 5.214

2.  The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.

Authors:  Juan F Viles-Gonzalez; Saibal Kar; Pamela Douglas; Srinivas Dukkipati; Ted Feldman; Rodney Horton; David Holmes; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

3.  PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.

Authors:  Yves-Laurent Bayard; Heyder Omran; Petr Neuzil; Leif Thuesen; Maximilian Pichler; Edward Rowland; Angelo Ramondo; Witold Ruzyllo; Werner Budts; Gilles Montalescot; Pedro Brugada; Patrick W Serruys; Alec Vahanian; Jean-François Piéchaud; Antonio Bartorelli; Jean Marco; Peter Probst; Karl-Heinz Kuck; Stefan H Ostermayer; Franziska Büscheck; Evelyn Fischer; Michaela Leetz; Horst Sievert
Journal:  EuroIntervention       Date:  2010-06       Impact factor: 6.534

Review 4.  Left atrial appendage: structure, function, and role in thromboembolism.

Authors:  N M Al-Saady; O A Obel; A J Camm
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

5.  Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience.

Authors:  Jai-Wun Park; Armando Bethencourt; Horst Sievert; Gennaro Santoro; Bernhard Meier; Kevin Walsh; Jose Ramon Lopez-Minguez; Jose Ramon Lopez-Minquez; David Meerkin; Mariano Valdés; Oliver Ormerod; Boris Leithäuser
Journal:  Catheter Cardiovasc Interv       Date:  2011-03-08       Impact factor: 2.692

6.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

7.  Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Authors:  Peter C Block; Steven Burstein; Paul N Casale; Paul H Kramer; Paul Teirstein; David O Williams; Mark Reisman
Journal:  JACC Cardiovasc Interv       Date:  2009-07       Impact factor: 11.195

8.  Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.

Authors:  Oluseun Alli; Shepal Doshi; Saibal Kar; Vivek Reddy; Horst Sievert; Chris Mullin; Vijay Swarup; Brian Whisenant; David Holmes
Journal:  J Am Coll Cardiol       Date:  2013-02-28       Impact factor: 24.094

9.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

10.  Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009.

Authors:  Anna C E Scowcroft; Sally Lee; Jonathan Mant
Journal:  Heart       Date:  2012-10-19       Impact factor: 5.994
View more
  6 in total

Review 1.  Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil.

Authors:  Renato D Lopes; Patricia O Guimarães; Elaine Hylek; Gilson S Feitosa-Filho; Luiz Ritt; Nivaldo Filgueiras; Eduardo Darzé; Mario S Rocha; Luis P Magalhães; Antonio Carlos Sobral Sousa; Luis Claudio Correia; Lucas Hollanda Oliveira; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

2.  Transcatheter closure of the left atrial appendage: initial experience with the WATCHMAN device.

Authors:  Jiandong Ding; Jian Zhu; Jing Lu; Xiuxia Ding; Xiaoli Zhang; Wenbin Lu; Mingqiang Ao; Genshan Ma
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Stereolithography for Personalized Left Atrial Appendage Occluders.

Authors:  Sanlin S Robinson; Cameron A Aubin; Thomas J Wallin; Saleh Gharaie; Patricia A Xu; Kaiyang Wang; Simon N Dunham; Bobak Mosadegh; Robert F Shepherd
Journal:  Adv Mater Technol       Date:  2018-09-21

4.  Bailout left atrial appendage occluder for pulmonary vein isolation and electrical cardioversion in patients with atrial fibrillation and left atrial appendage thrombus: a pilot study.

Authors:  Chin-Feng Tsai; Pang-Shuo Huang; Fu-Chun Chiu; Jien-Jiun Chen; Sheng-Nan Chang; Jung-Cheng Hsu; Su-Kiat Chua; Hsiao-Liang Cheng; Yi-Chih Wang; Juey-Jen Hwang; Chia-Ti Tsai
Journal:  Clin Res Cardiol       Date:  2022-09-02       Impact factor: 6.138

Review 5.  Imaging Endophenotypes of Stroke as a Target for Genetic Studies.

Authors:  Xueqiu Jian; Myriam Fornage
Journal:  Stroke       Date:  2018-05-14       Impact factor: 7.914

6.  Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.

Authors:  Wei-Ping Huang; Yong-Hua Zhang; Lei He; Xi Su; Xin-Wei Yang; Zai-Xiong Guo
Journal:  Chin Med J (Engl)       Date:  2017-02-20       Impact factor: 2.628
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.